ABLE K Electroporation-Competent Cells by Agilent Technologies
Manufacturer Agilent Technologies | Model: 200162
The ABLE C strain and the ABLE K strain help solve issues associated with toxic clones. The ABLE C strain reduces the copy number of ColE1-derived plasmids, e.g. pUC and pBluescript, by approximately 4-fold (compared to the XL1-Blue strain) and the ABLE K strain reduces the copy number of these plasmids approximately 10-fold.
ABLE K Electroporation-Competent Cells
The ABLE C strain and the ABLE K strain help solve issues associated with toxic clones. The ABLE C strain reduces the copy number of ColE1-derived plasmids, e.g. pUC and pBluescript, by approximately 4-fold (compared to the XL1-Blue strain) and the ABLE K strain reduces the copy number of these plasmids approximately 10-fold. This decreases the level of cloned protein product, increasing cell viability when proteins are toxic to the cells.
- F’ episome allows M13 infection
- Available as chemically and electroporation-competent cells
For Research Use Only. Not for Use in Diagnostic Procedures.
Product Overview
ABLE K Electroporation-Competent Cells
Manufacturer Agilent Technologies
Be the first to review this product
